Document:

Exhibit 10.9

                      ADDENDUM TO THE EMPLOYMENT AGREEMENT
    BETWEEN WILLIAM L. ALLENDER ("EXECUTIVE") AND CYTOMEDIX, INC. ("COMPANY")
              DATED MARCH 25, 2004 AND EFFECTIVE NOVEMBER 15, 2003

A. On September 30, 2004, the Company opened a new office at 416 Hungerford
Drive, Suite 330, Rockville, Maryland, 20850 (the "Maryland Office"). From the
date of this addendum until the earlier of (i) Executive's physical relocation
to the Washington, D.C. area, or (ii) the date the Executive and the Company
enter into a new employment agreement as provided in Paragraph D below (the "New
Contract Date"). Employee shall commute from his home in Dallas, Texas to the
Maryland Office (the "Commuting Period").

B. Effective September 1, 2004, the Executive's base salary shall be at a rate
of $110,000 per annum, with an additional incentive equal to $20,000 for the
Commuting Period. $15,000 of the incentive shall be paid to Executive on or
around April 20, 2005. The remaining $5,000 shall be paid upon the earlier of
(i) Executive's physical relocation to the Washington, D.C. area or (ii)
September 1, 2005.

C. During the Commuting Period, Executive shall have the option of returning to
Dallas on Friday afternoons and returning to the Washington, D.C. area on the
following Monday. At the Executive's option, Executive may assign this option to
a family member to allow them to come to the Washington, D.C. area. Any
additional expenses incurred through the use of this option shall be the
responsibility of Executive. Additionally, once adequate, competent staffing can
be hired and trained at the Maryland Office. Executive will have the right to
conduct Company business from his home one week out of every month at his
discretion and if circumstances allow during the Commuting Period. During the
Commuting Period, the Company shall reimburse the Executive for his travel and
similar expenses (including transportation between Dallas and the Washington,
D.C. area, housing in the Washington, D.C. area, and a vehicle for use in the
Washington, D.C. area) upon presentation, from time to time, of accounts of such
expenditures appropriately itemized and approved consistent with the Company's
policy. Additionally, during the Commuting Period, the Company shall pay
reasonable travel expenses for two trips for Executive's family to visit
Executive in the Washington, D.C. area.

D. Upon completion of the one year anniversary of the current contract between
the Company and the Chief Executive Officer, a new one-year employment agreement
will be negotiated between the Executive and the Board of Directors or their
Assigns. This employment agreement will be negotiated in good faith and will
compensate Executive at a rate commensurate with his responsibilities. That rate
will become effective on the date of the Executive's physical relocation to the
Washington, D.C. area. Upon Executive's physical relocation to the Washington,
D.C. area, the Company will pay for all moving costs for household goods
including any deposits required to facilitate obtaining adequate housing in the
Washington, D.C. area.
<PAGE>

E. In the event that Executive and Company are unable to agree on the terms of
the new employment agreement as provided in Paragraph D above and the current
Employment Agreement is terminated. Executive shall be entitled to conversion of
all vested stock options to five-year stock rights on a one to one basis at a
price equal to the option price with a cashless exercise provision and will be
accorded a six months severance package at the current rate of pay plus
hospitalization coverage as then provided by the Company. Further, Executive
agrees to remain with the Company upon the date of termination of the Employment
Agreement to recruit and train his successor for a maximum of ninety days. For
each thirty-day or partial period in which recruiting and training is necessary,
the severance period will be reduced fifteen days or at a ratio of 2 to 1 up ton
one and one half (1 1/2) months.

/s/ William L. Allender                                /s/ Kshitij Mohan
Mr. William L. Allender                                Mr. Kshitij Mohan
Chief Financial Officer                                Chief Executive Officer
Cytomedix, Inc.                                        Cytomedix, Inc.

Date:  9/30/04                                         Date:  9/9/04EXHIBIT 10.1
------------

September 2, 2004

Nathan Tarter
President
Ofer Yonach
Director
Nir Or Israel Ltd
11 Ha'amal St.,
Park Afek Rosh Ha'ayn
ISRAEL 48092

Gentlemen,

      The  purpose  of this  letter of  intent  is to set forth our  preliminary
understanding with respect to the proposed acquisition of the business of Nir Or
Israel  Ltd,  an Israeli  company  ("Nir  Or"),  by Voice  Diary Inc, a Delaware
company (the "BUYER"; that acquisition, the "Acquisition").

      1.   ACQUISITION.   The  parties  propose  that  at  the  closing  of  the
Acquisition, the Buyer will acquire the business of Nir Or by means of merger of
a subsidiary of the Buyer with Nir Or,  acquisition  of the assets of Nir Or, or
some  alternative  structure,  with the actual  structure  to be  determined  by
negotiation between us and you the shareholders of Nir Or (the  "Shareholders").
The purchase price and payment  instruments  and terms will be determined by the
parties in the forth coming negotiations.

      2. NEGOTIATIONS. Promptly after signing this letter of intent, the parties
shall  commence  negotiating  in good faith the terms of a definitive  agreement
providing for the Acquisition,  with a view to signing a definitive agreement on
or prior to December 31, 2004, and closing the Acquisition on or before February
15, 2005.

      3. ADDITIONAL PROVISIONS.

            (a) Nir Or and the Shareholders will prepare before the closing, Nir
Or's financial  statements  compatible with SEC requirements for the years ended
December  31, 2004 and  December  31,  2003,  and before the date of signing the
definitive agreement a business plan describing Nir Or's business and its future
plans to expand, especially in the American market.

            (b) The Buyer  does not  assume  by this  letter of intent or by any
further act with regard to the Acquisition,  any of the liabilities of Nir Or or
the  Shareholders  unless otherwise agreed in advance and in writing between the
Buyer and Nir Or or the Shareholders.

      4. DUE DILIGENCE.  Nir Or and the  Shareholders  shall  cooperate with the
Buyer's due  diligence  investigation  of Nir Or and shall provide the Buyer and
its  representatives  with prompt access,  on reasonable  advance notice, to key
employees and to the books, records, contracts, and other information pertaining
to Nir Or (the "DUE  DILIGENCE  INFORMATION").  For  purposes  of this letter of
intent,  Due Diligence  Information does not include  information that (1) is in
the possession of the Buyer at the time of disclosure, (2) prior to or after the
time of  disclosure  becomes  generally  available to the public other than as a
result of breach of this  agreement by the Buyer,  or (3) is approved for public
release by Nir Or or the Shareholders.

                                       19
<PAGE>

      5. EXCLUSIVE DEALING.  Until December 31, 2004, or the date of termination
of this letter of intent,  whichever comes first,  neither Nir Or nor any of the
Shareholders shall enter into any agreement, discussion, or negotiation with, or
provide  information  to, or solicit,  encourage,  entertain,  or  consider  any
inquiries or proposals  from, any other person or entity with respect to (1) the
possible  disposition of a material  portion of the assets of Nir Or, or (2) any
business combination involving Nir Or, whether by way of merger,  consolidation,
share exchange, or any other transaction.

      6. PUBLIC  ANNOUNCEMENT.  The parties  shall  advise and consult  with one
another  prior  to  issuance  of  any  public  announcements  pertaining  to the
Acquisition,  and neither Nir Or nor any of the Shareholders shall make any such
announcement without the prior written consent of the Buyer.

      7. EXPENSES. Each party shall bear its own its expenses, including without
limitation legal fees,  incurred in connection with negotiation and consummation
of the Acquisition.  Each party represents that it has not dealt with any broker
or finder or similar person in connection  with the  Acquisition and that it has
incurred no obligation or  liability,  contingent or otherwise,  for any fees to
any broker or find or similar person in connection  with the  Acquisition.  Each
party shall  indemnify  the other from any claim  (including  any legal or other
expenses  incurred in  connection  with the defense  thereof) for any  brokers',
finders' or similar fees incurred by the indemnifying party.

      8. CONFIDENTIALITY.  The Buyer shall not use any Due Diligence Information
for any purpose  other than the Buyer's due diligence  investigation  of Nir Or.
The Buyer shall not  disclose  the Due  Diligence  Information  to any person or
entity,  except that the Buyer may disclose  Due  Diligence  Information  to any
representative  of the Buyer who requires it in order to assist the Buyer in its
due diligence investigation of Nir Or. The Buyer shall take all reasonable steps
to  protect  the  confidentiality  of any Due  Diligence  Information  and shall
promptly  notify Nir Or of any misuse or  misappropriation  of any Due Diligence
Information that comes to its attention.

      9.  TERMINATION.  Any  party may  terminate  this  letter  of  intent  and
negotiations  regarding the Acquisition at any time by sending written notice to
the other  party.  The  obligations  contained  in  sections 5 through 8 survive
termination of this letter of intent.

      10.  COUNTERPARTS.  This  letter of intent may be  executed in two or more
counterparts,  each of which  shall  be an  original  but all of which  together
constitute one instrument.

      11.  GOVERNING  LAW.  All  matters  arising  out of this letter of intent,
including  without  limitation any tort claims,  are governed by the laws of the
State of New York, without giving effect to provisions  relating to conflicts of
law.

      12.  NON-BINDING.   Other  than  the  rights,  obligations,  and  policies
contained in section 2 and sections 4 through 12 of this letter of intent,  this
letter of intent is not binding on Nir Or, the Shareholders, or the Buyer and is
subject to  negotiation  and  execution  of a definitive  acquisition  agreement
between the Buyer and Nir Or and/or the Sellers.  The rights,  obligations,  and
policies contained in section 2 and sections 4 through 12 are binding on Nir Or,
the  Shareholders,  and the Buyer  whether or not the parties reach a definitive
agreement with respect to the Acquisition.

                                       20
<PAGE>

      If you are in  agreement  with the terms of this letter of intent,  please
sign in the space  provided  below and return a signed  copy to the Buyer at the
facsimile number stated below.

Yours sincerely,

Voice Diary Inc
By Arik Hinkis, President

Agreed to as of September 3, 2004

----------------------------------
Nir Or Israel Ltd

----------------------------------
Nathan Tarter, President

----------------------------------
Ofer Yonach, Director

                                       21

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00074-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00074-of-00352.parquet"}]]